The long-term prospects of Teladoc are completely intact. It's not the first time that Teladoc stock goes through a temporary drop. Read our analysis here.
Teladoc ( - Free Report) closed the most recent trading day at $156.99, moving -0.87% from the previous trading session. This change lagged the S&P 500's daily gain of 0.07%. The company is expected to report EPS of -$0.61, down 79.41% from the prior-year quarter.
Teladoc Health (NYSE:TDOC) had its price target lowered by equities research analysts at KeyCorp from $270.00 to $220.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an "overweight" rating on the health services provider's stock. KeyCorp's target price suggests a potential upside of 38.92% from the stock's current price.
Cathie Wood has been a fixture in the investing world for decades, but the founder and CEO of ARK Investment Management really took the spotlight in 2020 when her five flagship exchange-traded funds (ETFs) crushed the broader market results. In fact, each of her ETFs delivered gains of more than 100%.
The report presents an in-depth assessment of the Virtual Healthcare Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Virtual Healthcare from 2021 till 2026.
For the details of BINGHAM OSBORN & SCARBOROUGH LLC's stock buys and sells,go to https://www.gurufocus.com/guru/bingham+osborn+%26+scarborough+llc/current-portfolio/portfolio These are the top 5 holdings of BINGHAM OSBORN & SCARBOROUGH LLC S&P 500 ETF TRUST ETF (SPY) - 674,905 shares, 20.45% of the total portfolio. Shares reduced by 2.22% iShares Core S&P 500 ETF (IVV) - 530,948 shares, 16.10% of the total portfolio.
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always [...]
For the details of CAM Group Holding A's stock buys and sells,go to https://www.gurufocus.com/guru/cam+group+holding+a/current-portfolio/portfolio These are the top 5 holdings of CAM Group Holding A Visa Inc (V) - 5,172,266 shares, 10.72% of the total portfolio. Shares reduced by 2.13% Alphabet Inc (GOOG) - 461,832 shares, 9.35% of the total portfolio.
New York, NY, based Investment company Nikko Asset Management Americas, Inc. ( Current Portfolio) buys Square Inc, Shopify Inc, Teladoc Health Inc, Zoom Video Communications Inc, Tesla Inc, sells Taiwan Semiconductor Manufacturing Co, Splunk Inc, Lightspeed POS Inc, Workday Inc, Pure Storage Inc during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Nikko Asset Management Americas, Inc..
For the details of Oxler Private Wealth LLC's stock buys and sells,go to https://www.gurufocus.com/guru/oxler+private+wealth+llc/current-portfolio/portfolio These are the top 5 holdings of Oxler Private Wealth LLC Amazon.com Inc (AMZN) - 5,375 shares, 8.43% of the total portfolio. Shares added by 1.05% PowerShares QQQ Trust Ser 1 (QQQ) - 32,567 shares, 5.27% of the total portfolio.
The markets lately are a mix of gains and volatility, and it's tough, sometimes, for investors to make sense of it. In times like these, it makes sense to turn to the experts.
Teladoc Health (NYSE:TDOC) is a virtual healthcare company that offers a variety of care services, including primary care, mental health, chronic conditions, acute care and more. The company has caught the eye of many contrarian investors after the recent stock price crash, which was driven largely by the expectation of its pandemic-linked tailwinds disappearing.
Teladoc Health <<TDOC>> has come under pressure after Cantor Fitzgerald reiterated its commodity-like outlook on telehealth.Analysts Steven Halper and Kyle Mikson reaffirm...
Teladoc Health (TDOC) dropped ~5.3% today after Cantor Fitzgerald called telehealth a commodity citing a WSJ article in which a former Pepsicoexecutive highlighted a lost contactof...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Vertex Pharmaceuticals (), Teladoc () and Boston Scientific (). Vertex Pharmaceuticals (VRTX) In a report issued on April 29, Brian Skorney from Robert W. Baird maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $252.00.
Teladoc Health, Inc. (NYSE:TDOC) - Equities researchers at Oppenheimer decreased their Q2 2021 earnings per share (EPS) estimates for Teladoc Health in a research note issued to investors on Wednesday, April 28th. Oppenheimer analyst M. Wiederhorn now anticipates that the health services provider
MarketandResearch.biz has added new key research report titled Global Telemedicine Hardware and Services Market 2021 by Key Countries, Companies, Type and Application covering the industry market scenario. The study covers key fundamentals of the industry market. The research report will include total global revenues in the market with historical analysis, key figures including total revenues, total sales, key products, instrumental drivers, and challenges.
For the details of LaFleur & Godfrey LLC's stock buys and sells,go to https://www.gurufocus.com/guru/lafleur+%26+godfrey+llc/current-portfolio/portfolio These are the top 5 holdings of LaFleur & Godfrey LLC Apple Inc (AAPL) - 299,247 shares, 7.13% of the total portfolio. Shares added by 5.75% JPMorgan Chase & Co (JPM) - 160,093 shares, 4.76% of the total portfolio.
Introduction: Global Virtual Healthcare Market, 2020-28 The research report on global Virtual Healthcare market provides insightful data about market and all the important aspects related to it. The pattern in the Virtual Healthcare industry gives an absolute overview of prime players by the weightlessness of their product definition, company summary, and business strategy at intervals in the market.
WHITE PLAINS, N.Y., May 3, 2021 /PRNewswire/ -- Trellus Health, a leading resilience-driven connected health solution for chronic conditions, announced several important additions to its executive team and board of directors. Trellus Health Announces Experienced Leaders to Drive Next Phase of Growth The company named Alex Kozersky as Chief Sales Officer, Robert Birdsong as Chief Marketing Officer and Carole Romasco as Vice President of Product Management.